Ohio State Medical Oncology
@OhioStateMedOnc
Followers
669
Following
2K
Media
241
Statuses
1K
The OSU Division of Medical Oncology: providing cutting-edge compassionate care through team science to those diagnosed with solid tumor malignancies
Columbus, OH, USA
Joined January 2023
👏Congratulations to Dr. Sameek Roychowdhury (@OSUCCC_James GI Medical Oncologist) on receiving the @Pelotonia Researcher of the Year award!
0
5
21
👏Congrats, @HakimehNik!
What a wonderful time we had at #SITC2025! Honored to celebrate this year’s Young Investigator Travel Awardees 🌟 Special congratulations to @HakimehNik @OSUCCC_James @OhioStateMedOnc @OSU_PIIO — recognized for outstanding, high-impact research advancing immuno-oncology. 👏
0
0
3
📝New publication from @dwightowenmd & colleagues: Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy #NSCLC #immunotherapy
0
1
5
Excited to kick off the @IASLC #HT25 with my co-chair Dr. Aaron Tan, opening keynote speaker Dr. Daniel Tan and Special honored speaker- Dr. PC Yang. #HT25 @IASLC #LCSM @OncoAlert @oncodaily @lcsmchat @JSMO_official @JLCS_OFFICIAL @OhioStateMedOnc @OhioStateWIMS @OSUCCC_James
0
2
16
Congrats Dr. Mortazavi for his talk at Bermuda @DAVAOnc Bladder cancer treatment options @OSU_Urology @OhioStateMedOnc @OhioStateMed
1
3
6
👏Thanks to all of the riders, volunteers, and fundraisers!
Record of funding for @Pelotonia in Cancer Research to @OSUCCC_James more than 29 M! 💚💚💚💚 Thanks for our amazing community!!! @OhioStateMedOnc
0
3
6
📝New publication from @TheodoreWagener & colleagues in @AmJPrevMed: Young adults’ responses to e-cigarette advertisements: An examination for potential regulation @OhioStateCTR
https://t.co/XwvgMO3Qou
0
1
2
Dr @dwightowenmd from @OhioStateMedOnc highlights the fact that all treatment decisions for NSCLC prior to initiating therapy are contingent upon results of molecular profiling. We should not omit this critical step even in earlier staged disease. @HenryFordHealth
1
4
21
Join @triparnasen in Tokyo, Japan, November 21–23, 2025!
Don’t miss the @IASLC 2025 Hot Topic Meeting in Nov! Thrilled to have @triparnasen, Professor @OhioStateMedOnc, as conference Co-Chair, leading this dynamic gathering of world experts exploring early #lungcancer. #HT25 #LungCancerAwarenessMonth #LungCancerResearch @OhioState
0
1
2
🚨We are hiring Breast Medical Oncologists @OSUCCC_James! Connect with our Breast Section Chief, Dr. Margaret Gatti-Mays at #SABCS2025 Please send CVs with interest to storm.wilkins@osumc.edu @HemOncFellows
0
5
11
New clinical trial led by Dr. Konda from our endocrine medical oncology team
New trial! Bhavana Konda, MD, MPH, of @OhioStateMedOnc leads @alliance_org A092204 exploring if using two targeted medications can help slow tumor growth in people with advanced adrenocortical carcinoma, a rare cancer of the adrenal glands. https://t.co/nRecgtTEYB
#NCI
0
1
5
📝New publication from @triparnasen & colleagues: Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity https://t.co/CeeTXOYbEi
0
1
1
🎉 Mank thanks to @HakimehNik, for her #SITC2025 talk titled “Mechanistic Role of Signal Peptide Peptidase in Qa-1–Mediated Antigen Presentation and #TumorImmunity.” @OhioStateMedOnc @OhioStatePIIO @OSUCCC_James
0
3
7
Thanks to the 🇮🇹 Italian Association of Medical Oncology @AIOMtweet for the kind invitation to participate in the Annual Congress #AIOM25 discussion on #liquidbiopsy with @antoniorusso_pa @FabioPagni1 @UmbertoMalapel1 & others. @isliquidbiopsy @OSUCCC_James
@OhioStateMedOnc 🇺🇸
1
7
41
Many thanks to Dr. @JKaufmanLungNED & team for representing @OhioStateMedOnc, @OhioStatePIIO, @OSUCCC_James at #SITC2025. Talk title: “Lineage plasticity influences #immune_evasion in STK11-deficient #NSCLC via S100A8/A9-driven #Tcell dysfunction.” @OhioState @OSUCCC_James
0
2
3
👏Congrats to Mark Vater of @StoverLab on receiving an @SABCSSanAntonio Basic Science Scholars Award!
0
0
8
📝New publication from @ChristianRolfo, @RobertoBoreaMD & colleagues in @jlb_islb: Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies
0
3
12